Vincerx Pharma Inc. (NASDAQ:VINC) saw an upside of 6.94% to $0.92 after adding $0.06 on Tuesday. The 5-day average trading volume is 341,896 shares of the company’s common stock. It has gained $0.9650 in the past week and touched a new high 4 times within the past 5 days. An average of 236,734 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 142,606.
VINC’s 1-month performance is -23.33% or -$0.3675 on its low of $0.8040 reached on 08/16/23. The company’s shares have touched a 52-week low of $0.63 and high of $1.95, with the stock’s rally to the 52-week high happening on 06/07/23. YTD, VINC has lost -9.80% or -$0.0975 and has reached a new high 20 times. However, the current price is down -52.82% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
VINC stock has a beta of 0.34. Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 0.81.
Vincerx Pharma Inc.’s quick ratio for the period ended June 29 was 3.50, with the current ratio over the same period at 3.50.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income shrunk -65.2% to -$11.15 million, while revenue of -$14.34 million was -28.61% off the previous quarter. Analysts expected VINC to announce -$0.6 per share in earnings in its latest quarter, but it posted -$0.52, representing a 13.30% surprise. VINC stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 11.14 million, with total debt at $3.02 million. Shareholders hold equity totaling $21.38 million.
Let’s look briefly at Vincerx Pharma Inc. (VINC) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 21 August was 47.81% to suggest the stock is trending Neutral, with historical volatility in this time period at 67.69%.
The stock’s 5-day moving average is $0.8606, reflecting a +7.27% or $0.0625 change from its current price. VINC is currently trading -7.75% above its 20-day SMA, -9.56% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -48.17% and SMA200 by-13.79%.
Stochastic %K and %D was 32.86% and 21.01% and the average true range (ATR) pointed at 0.0891. The RSI (14) points at 42.51%, while the 14-day stochastic is at 63.71% with the period’s ATR at 0.0970. The stock’s 9-day MACD Oscillator is pointing at -0.0121 and -0.0219 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Vincerx Pharma Inc. (NASDAQ: VINC), H.C. Wainwright launched coverage with a Buy rating. Analysts offering their rating for VINC stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate VINC as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.
What is VINC’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $4.00 and a high of $10.00, with their median price target at $5.00. Looking at these predictions, the average price target given by analysts is for Vincerx Pharma Inc. (VINC) stock is $6.33.
